Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sweet

Showing results (301-310 of 322) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Oxidative stress and serum deprivation influence the evolution of newly formed tetraploid cells during tumorigenesisMegan L Sweet, Mathew Bloomfield, Nicholas Keen, et al.
Cancer Research|January 22, 2026
Cell and Nuclear Size are Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells that Undergo Whole Genome DoublingMathew Bloomfield, Sydney M Huth, Daniella S McCausland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.
Haematologica|January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness levelNaveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.
Sexually Transmitted Diseases|April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosisC H Livengood, D E Soper, K L Sheehan, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
American Journal of Hematology|February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Controlled Clinical Trials|September 19, 1998
Design of the PID Evaluation and Clinical Health (PEACH) StudyR B Ness, D E Soper, J Peipert, et al.
American Journal of Obstetrics and Gynecology|May 17, 2002
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized TrialRoberta B Ness, David E Soper, Robert L Holley, et al.
Cancer|September 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutationsSomedeb Ball, Todd C Knepper, Yehuda E Deutsch, et al.
Pageof 33

Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Oxidative stress and serum deprivation influence the evolution of newly formed tetraploid cells during tumorigenesisMegan L Sweet, Mathew Bloomfield, Nicholas Keen, et al.
Cancer Research|January 22, 2026
Cell and Nuclear Size are Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells that Undergo Whole Genome DoublingMathew Bloomfield, Sydney M Huth, Daniella S McCausland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.
Haematologica|January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness levelNaveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.
Sexually Transmitted Diseases|April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosisC H Livengood, D E Soper, K L Sheehan, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
American Journal of Hematology|February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Controlled Clinical Trials|September 19, 1998
Design of the PID Evaluation and Clinical Health (PEACH) StudyR B Ness, D E Soper, J Peipert, et al.
American Journal of Obstetrics and Gynecology|May 17, 2002
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized TrialRoberta B Ness, David E Soper, Robert L Holley, et al.
Cancer|September 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutationsSomedeb Ball, Todd C Knepper, Yehuda E Deutsch, et al.
Pageof 33